Stock News and Filings Feed


Add 500084
to your dashboard

With New Patent, Cesca Eyes Faster, Less Costly CAR-T Cell Production

2017-07-31 genengnews
Chimeric antigen receptor T-cell receptor (CAR-T) and CAR-modified natural killer (CAR-NK) therapeutics can be produced faster and at less cost, Cesca Therapeutics says, through the cellular processing technology covered by a recently-awarded patent.

Corporate News Blog - Cesca Therapeutics Announces Issuance of New Cellular Processing Patent

2017-07-31 accesswire
LONDON, UK / ACCESSWIRE / July 31, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Cesca Therapeutics Inc. (NASDAQ: KOOL) ("Cesca"), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=KOOL. The Company, which is a market leader in automated cell processing, announced on July 28, 2017, that the US Patent and Trademark Office has awarded a new US Patent (the ‘394 patent'), entitled Cell Separation Devices, Systems, and Methods to SynGen, Inc.

Featured Company News - Cesca Therapeutics Acquires Cell Processing Systems from SynGen through its Device Business, ThermoGenesis

2017-07-12 accesswire
LONDON, UK / ACCESSWIRE / July 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Cesca Therapeutics Inc. (NASDAQ: KOOL), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=KOOL. The Company announced on July 10, 2017, that its wholly-owned subsidiary, ThermoGenesis Corp., has entered into an asset acquisition agreement with SynGen, Inc.

Company News for July 11, 2017

2017-07-11 zacks
•    Shares of Hawaiian Telcom Holdco, Inc. surged 18.1% following news that Cincinnati Bell (CBB - Free Report) has decided to acquire the company for $650 million •    Cesca Therapeutics Inc's soared 16.9% after the company purchased SynGen Inc.’s cell processing systems •    Shares of ClubCorp Holdings, Inc. (MYCC - Free Report) skyrocketed 30.2% following news that Apollo Global Management (APO - Free Report) has agreed to acquire the company for $1.

The Alliance for Regenerative Medicine Releases Agenda for Inaugural Cell & Gene Exchange

2017-05-09 marketwired
WASHINGTON, DC--(Marketwired - May 9, 2017) - The Alliance for Regenerative Medicine (ARM) today released the agenda for the inaugural Cell & Gene Exchange, the only partnering conference that brings together the regulatory, business and patient advocacy communities across the cell and gene therapy sectors. Co-produced by ARM and EBD Group and held in partnership with Global Genes, the event will take place May 22 and 23 in Washington, D.

Fintel IR - Find the Right Investors for Your Company, Instantly!

Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!